Novel genomic signals of recent selection in an Ethiopian population

European Journal of Human Genetics

Volumn 23, Issue 8, 2015, Pages 1085-1092

  Tekola Ayele, Fasil ^a   Adeyemo, Adebowale ^a   Chen, Guanjie ^a   Hailu, Elena ^b   Aseffa, Abraham ^b   Davey, Gail ^c   Newport, Melanie J ^c   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; ANTIPORTER; CDKAL1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HLA A ANTIGEN; NEGR1 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SLC24A5 PROTEIN, HUMAN; TRANSFER RNA METHYLTRANSFERASE;

ADAPTATION; AFRICAN; ALLELE; ALTITUDE DISEASE; ARTICLE; CDKAL1 GENE; CHROMOSOME 6; CONTROLLED STUDY; DIABETES MELLITUS; EAST AFRICAN; ENERGY METABOLISM; ENSET; ETHIOPIA; ETHIOPIAN; ETHNICITY; FOOD DEPRIVATION; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENOMICS; HAPLOTYPE MAP; HUMAN; HYPOXIA; INTRON; MAJOR CLINICAL STUDY; METABOLISM; NEGR1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLANT; PODOCONIOSIS; PPARA GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN PIGMENTATION; SURVIVAL; ELEPHANTIASIS; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; MALE; PATHOLOGY; PATHOPHYSIOLOGY; POPULATION GENETICS;

ANTIPORTERS; CELL ADHESION MOLECULES, NEURONAL; CYCLIN-DEPENDENT KINASE 5; ELEPHANTIASIS; ENERGY METABOLISM; ETHIOPIA; FEMALE; GENETICS, POPULATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GPI-LINKED PROTEINS; HAPMAP PROJECT; HLA-A ANTIGENS; HUMANS; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR ALPHA; SELECTION, GENETIC; SKIN PIGMENTATION; TRNA METHYLTRANSFERASES;

EID: 84937516321     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.233     Document Type: Article

References (67)

1. Pickrell JK, Coop G, Novembre J et al: Signals of recent positive selection in a worldwide sample of human populations. Genome Res 2009; 19: 826-837.
2. Klimentidis YC, Abrams M, Wang J, Fernandez JR, Allison DB: Natural selection at genomic regions associated with obesity and type-2 diabetes: East Asians and sub-Saharan Africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet 2011; 129: 407-418.
3. Guinan KJ: Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. Biochem Genet 2012; 50: 159-179.
4. Hamblin MT, Di Rienzo A: Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus. Am J Hum Genet 2000; 66: 1669-1679.
5. Tishkoff SA, Reed FA, Ranciaro A et al: Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet 2007; 39: 31-40.
6. Ayodo G, Price AL, Keinan A et al: Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. Am J Hum Genet 2007; 81: 234-242.
7. Grossman SR, Andersen KG, Shlyakhter I et al: Identifying recent adaptations in large-scale genomic data. Cell 2013; 152: 703-713.
8. Karlsson EK, Kwiatkowski DP, Sabeti PC: Natural selection and infectious disease in human populations. Nat Rev Genet 2014; 15: 379-393.
9. Akey JM: Constructing genomic maps of positive selection in humans: where do we go from here? Genome Res 2009; 19: 711-722.
10. Campbell MC, Tishkoff SA: African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008; 9: 403-433.
11. Tekola-Ayele F, Adeyemo A, Aseffa A et al: Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population. Pharmacogenomics J 2015; 15: 101-108.
12. Tekola Ayele F, Adeyemo A, Finan C et al: HLA class II locus and susceptibility to podoconiosis. N Engl J Med 2012; 366: 1200-1208.
13. Altshuler DM, Gibbs RA, Peltonen L et al: Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52-58.
14. Voight BF, Kudaravalli S, Wen X, Pritchard JK: A map of recent positive selection in the human genome. PLoS Biol 2006; 4: e72.
15. Sabeti PC, Varilly P, Fry B et al: Genome-wide detection and characterization of positive selection in human populations. Nature 2007; 449: 913-918.
16. Scheet P, Stephens M: A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
17. Andres AM, Clark AG, Shimmin L, Boerwinkle E, Sing CF, Hixson JE: Understanding the accuracy of statistical haplotype inference with sequence data of known phase. Genet Epidemiol 2007; 31: 659-671.
18. Reynolds J, Weir BS, Cockerham CC: Estimation of the coancestry coefficient: basis for a short-term genetic distance. Genetics 1983; 105: 767-779.
19. Wagh K, Bhatia A, Alexe G et al: Lactase persistence and lipid pathway selection in the Maasai. PLoS One 2012; 7: e44751.
20. Mi H, Muruganujan A, Thomas PD: PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 2013; 41: D377-D386.
21. Scheinfeldt LB, Soi S, Thompson S et al: Genetic adaptation to high altitude in the Ethiopian highlands. Genome Biol 2012; 13: R1.
22. Liu X, Ong RT, Pillai EN et al: Detecting and characterizing genomic signatures of positive selection in global populations. Am J Hum Genet 2013; 92: 866-881.
23. Ong RT, Liu X, Poh WT, Sim X, Chia KS, Teo YY: A method for identifying haplotypes carrying the causative allele in positive natural selection and genome-wide association studies. Bioinformatics 2011; 27: 822-828.
24. Morris AP, Voight BF, Teslovich TM et al: Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012; 44: 981-990.
25. Saxena R, Elbers CC, Guo Y et al: Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012; 90: 410-425.
26. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L: Natural selection has driven population differentiation in modern humans. Nat Genet 2008; 40: 340-345.
27. Jarvis JP, Scheinfeldt LB, Soi S et al: Patterns of ancestry, signatures of natural selection, and genetic association with stature in Western African pygmies. PLoS Genet 2012; 8: e1002641.
28. Williamson SH, Hubisz MJ, Clark AG, Payseur BA, Bustamante CD, Nielsen R: Localizing recent adaptive evolution in the human genome. PLoS Genet 2007; 3: e90.
29. Cao K, Moormann AM, Lyke KE et al: Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004; 63: 293-325.
30. Bhatia G, Patterson N, Pasaniuc B et al: Genome-wide comparison of African-ancestry populations from CARe and other cohorts reveals signals of natural selection. Am J Hum Genet 2011; 89: 368-381.
31. Barreiro LB, Quintana-Murci L: From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 2010; 11: 17-30.
32. Bubb KL, Bovee D, Buckley D et al: Scan of human genome reveals no new Loci under ancient balancing selection. Genetics 2006; 173: 2165-2177.
33. DeGiorgio M, Lohmueller KE, Nielsen R: A model-based approach for identifying signatures of ancient balancing selection in genetic data. PLoS Genet 2014; 10: e1004561.
34. Solberg OD, Mack SJ, Lancaster AK et al: Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 2008; 69: 443-464.
35. Andres AM, Hubisz MJ, Indap A et al: Targets of balancing selection in the human genome. Mol Biol Evol 2009; 26: 2755-2764.
36. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F: Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005; 15: 1022-1027.
37. Sanchez-Mazas A, Lemaitre JF, Currat M: Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments. Philos Trans R Soc Lond B Biol Sci 2012; 367: 830-839.
38. Dunn RR, Davies TJ, Harris NC, Gavin MC: Global drivers of human pathogen richness and prevalence. Proc Biol Sci 2010; 277: 2587-2595.
39. Henze PB: Layers of Time: A History of Ethiopia. London: Palgrave Macmillan, 2004.
40. Okada Y, Kubo M, Ohmiya H et al: Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat Genet 2012; 44: 302-306.
41. Kwak SH, Choi SH, Jung HS et al: Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab 2013; 98: E744-E752.
42. Ng MC, Saxena R, Li J et al: Transferability and fine mapping of type 2 diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study. Diabetes 2013; 62: 965-976.
43. Pascoe L, Tura A, Patel SK et al: Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007; 56: 3101-3104.
44. Ubeda M, Rukstalis JM, Habener JF: Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 2006; 281: 28858-28864.
45. Wei FY, Nagashima K, Ohshima T et al: Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 2005; 11: 1104-1108.
46. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770-775.
47. Prentice AM, Hennig BJ, Fulford AJ: Evolutionary origins of the obesity epidemic: natural selection of thrifty genes or genetic drift following predation release? Int J Obes (Lond) 2008; 32: 1607-1610.
48. Nakayama K, Ogawa A, Miyashita H et al: Positive natural selection of TRIB2, a novel gene that influences visceral fat accumulation, in East Asia. Hum Genet 2013; 132: 201-217.
49. Lefebvre P, Chinetti G, Fruchart JC, Staels B: Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006; 116: 571-580.
50. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-1498.
51. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS: Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000; 275: 28918-28928.
52. Leone TC, Weinheimer CJ, Kelly DP: A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999; 96: 7473-7478.
53. Reddy JK, Hashimoto T: Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001; 21: 193-230.
54. Brandt SA, Spring A, Hiebsch C et al: The "Tree Against Hunger". Enset-based Agricultural Systems in Ethiopia. Washington, DC: American Association for the Advancement of Science, 1997.
55. Ehret C: On the antiquity of agriculture in Ethiopia. J Afr Hist 1979; 20: 161-177.
56. Ge RL, Simonson TS, Cooksey RC et al: Metabolic insight into mechanisms of high-altitude adaptation in Tibetans. Mol Genet Metab 2012; 106: 244-247.
57. Simonson TS, Yang Y, Huff CD et al: Genetic evidence for high-altitude adaptation in Tibet. Science 2010; 329: 72-75.
58. Shin MJ, Kanaya AM, Krauss RM: Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis 2008; 198: 313-319.
59. Kimura R, Takahashi N, Murota K et al: Activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes. Biochem Biophys Res Commun 2011; 410: 1-6.
60. Tesfaye F: Epidemiology of Cardiovascular Disease Risk Factors in Ethiopia: The rural-urban gradient, PhD thesis Umea: Umeå University, 2008.
61. Misganaw A, Mariam DH, Araya T, Ayele K: Patterns of mortality in public and private hospitals of Addis Ababa, Ethiopia. BMC Public Health 2012; 12: 1007.
62. Pagani L, Kivisild T, Tarekegn A et al: Ethiopian genetic diversity reveals linguistic stratification and complex influences on the Ethiopian gene pool. Am J Hum Genet 2012; 91: 83-96.
63. Beleza S, Santos AM, McEvoy B et al: The timing of pigmentation lightening in Europeans. Mol Biol Evol 2013; 30: 24-35.
64. Raj T, Kuchroo M, Replogle JM, Raychaudhuri S, Stranger BE, De Jager PL: Common risk alleles for inflammatory diseases are targets of recent positive selection. Am J Hum Genet 2013; 92: 517-529.
65. Yakob B, Deribe K, Davey G: High levels of misconceptions and stigma in a community highly endemic for podoconiosis in southern Ethiopia. Trans R Soc Trop Med Hyg 2008; 102: 439-444.
66. Tora A, Davey G, Tadele G: A qualitative study on stigma and coping strategies of patients with podoconiosis in Wolaita zone, Southern Ethiopia. Int Health 2011; 3: 176-181.
67. Tekola F, Bull S, Farsides B et al: Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: a qualitative study. BMC Med Ethics 2009; 10: 13.